Daiichi Sankyo Co., Ltd. revenue for the last year amounted to 10.58 B USD, the most of which — 9.08 B USD — came from its highest performing source at the moment, Prescription Drugs, the year earlier bringing 8.03 B USD. The greatest contribution to the revenue figure was made by Japan — last year it brought Daiichi Sankyo Co., Ltd. 4.02 B USD, and the year before that — 4.59 B USD.